Cargando…

Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease

BACKGROUND: The impact of early peripheral blood chimerism on the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) is unclear. We aimed to determine whether day 14 peripheral blood chimerism after allo-HSCT predicts outcomes in patients with non-malignant diseases. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Young Bae, Lee, Ji Won, Sung, Ki Woong, Koo, Hong Hoe, Kim, Hee-Jin, Yoo, Keon Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374552/ https://www.ncbi.nlm.nih.gov/pubmed/30787679 http://dx.doi.org/10.3346/jkms.2019.34.e46

Ejemplares similares

Erratum: Correction of Title: Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
por: Choi, Young Bae, et al.
Publicado: (2019)

Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients
por: Lee, Sae-Mi, et al.
Publicado: (2017)

Hematopoietic stem cell transplantation in children with acute leukemia: similar outcomes in recipients of umbilical cord blood versus marrow or peripheral blood stem cells from related or unrelated donors
por: Yi, Eun Sang, et al.
Publicado: (2012)

Rapid Determination of Chimerism Status Using Dihydrorhodamine Assay in a Patient with X-linked Chronic Granulomatous Disease Following Hematopoietic Stem Cell Transplantation
por: Kim, Hyun-Young, et al.
Publicado: (2013)

High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Children with High-Risk or Recurrent Bone and Soft Tissue Sarcomas
por: Choi, Young Bae, et al.
Publicado: (2016)

Clinical implications of chimerism after allogeneic hematopoietic stem cell transplantation in children with non-malignant diseases
por: Park, Meerim, et al.
Publicado: (2011)

Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma
por: Lee, Na Hee, et al.
Publicado: (2016)

NUDT15 Variants Cause Hematopoietic Toxicity with Low 6-TGN Levels in Children with Acute Lymphoblastic Leukemia
por: Yi, Eun Sang, et al.
Publicado: (2018)

Iron Overload during Follow-up after Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with High-Risk Neuroblastoma
por: Bae, Soo Jin, et al.
Publicado: (2012)

Very Long Term Stability of Mixed Chimerism after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies
por: Levrat, Emmanuel, et al.
Publicado: (2015)

Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges
por: Lee, Myoung Woo, et al.
Publicado: (2019)

Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)

Optimal Time to Start Peripheral Blood Stem Cell Collection in Children with High-Risk Solid Tumors
por: Sung, Ki Woong, et al.
Publicado: (2014)

Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma
por: Kim, Chiwoo, et al.
Publicado: (2018)

Conditioning with 10 Gy Total Body Irradiation, Cyclophosphamide, and Fludarabine without ATG Is Associated with Improved Outcome of Cord Blood Transplantation in Children with Acute Leukemia
por: Cho, Hee Won, et al.
Publicado: (2021)

Scabies mimicking graft versus host disease in a hematopoietic cell transplant recipient
por: Kim, Dongsub, et al.
Publicado: (2018)

The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children
por: Park, Meerim, et al.
Publicado: (2011)

Therapy-related myeloid neoplasms in children and adolescents
por: Cho, Hee Won, et al.
Publicado: (2016)

Infectious Complications during Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Children with High-Risk or Recurrent Solid Tumors
por: Choi, Young Bae, et al.
Publicado: (2016)

Digital PCR Panel for Sensitive Hematopoietic Chimerism Quantification after Allogeneic Stem Cell Transplantation
por: Stahl, Tanja, et al.
Publicado: (2016)

Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation
por: Kanaan, Sami B., et al.
Publicado: (2023)

Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center Study
por: Cho, Hee Won, et al.
Publicado: (2018)

Impact of the histologic grade of acute gastrointestinal graft-versus-host disease on outcomes in pediatric patients treated with allogeneic hematopoietic stem cell transplantation
por: Kim, Eun Sil, et al.
Publicado: (2023)

Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation
por: Huang, Wen-Rong, et al.
Publicado: (2018)

Clinical significance of germline telomere length and associated genetic factors in patients with neuroblastoma
por: Bae, Joon Seol, et al.
Publicado: (2022)

Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders
por: Mahmoud, Hossam K., et al.
Publicado: (2015)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies
por: Zahid, Mohammad Faizan, et al.
Publicado: (2014)

Incorporation of high-dose (131)I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
por: Lee, Ji Won, et al.
Publicado: (2017)

Double umbilical cord blood transplantation for children and adolescents
por: Kang, Hyoung Jin, et al.
Publicado: (2010)

Chimerism Testing by Next Generation Sequencing for Detection of Engraftment and Early Disease Relapse in Allogeneic Hematopoietic Cell Transplantation and an Overview of NGS Chimerism Studies
por: Liacini, Abdelhamid, et al.
Publicado: (2023)

Excellent outcome of medical treatment for Kasabach-Merritt syndrome: a single-center experience
por: Kim, Jin Ah, et al.
Publicado: (2016)

Tandem High-dose Chemotherapy without Craniospinal Irradiation in Treatment of Non-metastatic Malignant Brain Tumors in Very Young Children
por: Ma, Youngeun, et al.
Publicado: (2020)

Toxoplasma Encephalitis in an Allogeneic Hematopoietic Stem Cell Transplant Recipient in Korea
por: Park, Soo-Kyung, et al.
Publicado: (2012)

Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Concurrent Lymphoid Malignancy
por: Zimmerman, Zachary, et al.
Publicado: (2011)

Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy
por: Dillon, Hayley T., et al.
Publicado: (2022)

Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies
por: Saygin, Caner, et al.
Publicado: (2022)

Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Atypical Teratoid/Rhabdoid Tumor
por: Sung, Ki Woong, et al.
Publicado: (2016)

Chimerism in the Realm of Hematopoietic Stem Cell Transplantation for Non-malignant Disorders—A Perspective
por: Zimmerman, Clare, et al.
Publicado: (2020)

The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: High incidence compared with general population
por: Lee, Hyo-Jin, et al.
Publicado: (2017)

Genome-Wide Association Study for the Identification of Novel Genetic Variants Associated with the Risk of Neuroblastoma in Korean Children
por: Bae, Joon Seol, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fhhju3tsp6uvtfbmg3ku5vm6i1